Generated by GPT-5-mini| Keogh Review | |
|---|---|
| Name | Keogh Review |
| Caption | Report cover (2013) |
| Author | Sir Bruce Keogh |
| Date | 2013 |
| Country | United Kingdom |
| Subject | Healthcare quality and patient safety |
Keogh Review The Keogh Review was a 2013 independent inquiry led by Sir Bruce Keogh into hospitals with higher-than-expected mortality rates in England, commissioned by NHS England and informed by concerns raised in the aftermath of the Francis Inquiry, the Winterbourne View scandal, and media coverage such as that by BBC News and The Guardian. The review examined patient safety in acute hospitals, drawing on data from the Care Quality Commission, the National Institute for Health and Care Excellence, and international comparisons with systems in United States, Canada, and Australia.
The review was initiated after scrutiny following the Francis Inquiry into failures at Mid Staffordshire NHS Foundation Trust and high-profile cases including Dorset County Hospital reporting and the exposure of failings at Broomfield Hospital and Basildon Hospital. Sir Bruce Keogh, formerly of University College London Hospitals NHS Foundation Trust and a former medical director of NHS England, was appointed to assess 14 trusts identified from mortality indicators developed with the Dr Foster Unit and the Healthcare Quality Improvement Partnership. The purpose was to evaluate patient outcomes at trusts such as Liverpool University Hospitals NHS Foundation Trust, North Staffordshire Hospitals NHS Trust, and University Hospitals of Morecambe Bay NHS Foundation Trust and to recommend systemic improvements alongside regulators including the Care Quality Commission and commissioners such as Clinical Commissioning Groups.
Keogh identified failures in leadership at trusts exemplified by incidents at Basildon and Thurrock University Hospitals NHS Foundation Trust and systemic problems similar to those highlighted by the Bristol Royal Infirmary Inquiry and the Alder Hey Children's Inquiry. Key findings included inadequate clinical governance, failures in board oversight noted in comparisons with governance models at Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital, and poor patient engagement similar to issues raised in the Shipman inquiry. Recommendations urged enhanced board-level clinical scrutiny akin to practices at Royal Marsden NHS Foundation Trust and creation of escalation frameworks mirrored in Institute for Healthcare Improvement initiatives. Specific measures called for stronger roles for Medical directors (UK), empowered Nursing Directors as seen at Great Ormond Street Hospital, mandatory publication of mortality reviews similar to transparency advocated by Healthwatch England, and implementation of national standards from National Institute for Health and Care Excellence. The report advocated greater use of data from Hospital Episode Statistics, strengthened inspection powers for the Care Quality Commission, and collaboration with professional bodies including the General Medical Council, the Royal College of Nursing, and Academy of Medical Royal Colleges.
Following publication, NHS England and the Department of Health and Social Care established interventions such as the Keogh-led review teams working alongside trusts like Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust and Portsmouth Hospitals University NHS Trust. The Care Quality Commission adopted revised inspection frameworks drawing on models from Healthcare Improvement Scotland and regulators such as Joint Commission (United States). Clinical governance reforms were implemented across trusts informed by networks including the Patient Safety Collaborative program and projects led by National Reporting and Learning System. Changes included appointment of new chief executives at affected trusts, board training with partners like NHS Leadership Academy, and creation of patient involvement forums modeled on INVOLVE (UK). Outcomes measured by reductions in standardized mortality ratios were reported in some trusts, with benchmarking against international indicators used by Organisation for Economic Co-operation and Development health data.
The review was welcomed by figures including Jeremy Hunt and leaders of NHS Providers but faced criticism from patient advocates and unions such as Royal College of Nursing and British Medical Association for focusing on processes over staffing concerns raised in reports by Kings Fund and Nuffield Trust. Critics argued parallels with earlier inquiries like the Shipman Inquiry and Bristol Inquiry, contending that recommendations did not sufficiently address systemic funding pressures cited by King's Fund analyses or the workforce shortages highlighted by Health Education England and Royal College of Physicians. Commentators in outlets such as The Independent and Financial Times debated the reliance on statistical triggers from Dr Foster Intelligence and the potential for false positives similar to controversies around the Hospital Standardised Mortality Ratio.
The review influenced later policy including strengthened inspection regimes and integration of patient safety into NHS Long Term Plan initiatives, and informed the development of regional support structures akin to Sustainability and Transformation Partnerships and Integrated Care Systems. Its emphasis on transparency and leadership fed into reforms led by figures such as Simon Stevens and programs from NHS Improvement now part of NHS England’s regulatory framework. Keogh’s work is cited alongside other major inquiries like the Francis Inquiry and Berwick Report as shaping modern patient safety culture in England, contributing to ongoing debates involving stakeholders including the Care Quality Commission, Royal Colleges, think tanks like Institute for Government and Social Market Foundation, and advocacy groups such as Healthwatch England.
Category:Health reviews